BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22430872)

  • 1. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
    Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
    J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
    Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
    J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.
    Nipp M; Elsner M; Balluff B; Meding S; Sarioglu H; Ueffing M; Rauser S; Unger K; Höfler H; Walch A; Zitzelsberger H
    J Mol Med (Berl); 2012 Feb; 90(2):163-74. PubMed ID: 21938494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary study of lymph node metastasis-related serum biomarkers in breast cancer.
    Wang L; Su D; Yan HJ; Xu JH; Zheng ZG; Hu YJ; Pan XD; Ding XW; Chen C; Chen B; Mao WM; Meng XL
    Anat Rec (Hoboken); 2011 Nov; 294(11):1818-24. PubMed ID: 21964916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.
    Karamitopoulou E; Zlobec I; Patsouris E; Peros G; Lugli A
    Pathology; 2011 Feb; 43(2):133-7. PubMed ID: 21233674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-CoA thioesterase 8 is a specific protein related to nodal metastasis and prognosis of lung adenocarcinoma.
    Jung WY; Kim YH; Ryu YJ; Kim BH; Shin BK; Kim A; Kim HK
    Pathol Res Pract; 2013 May; 209(5):276-83. PubMed ID: 23540296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
    Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
    BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis.
    Sun L; Pan J; Peng L; Fang L; Zhao X; Sun L; Yang Z; Ran Y
    Ann Surg Oncol; 2012 Jul; 19(7):2411-9. PubMed ID: 22219064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.
    Balluff B; Rauser S; Meding S; Elsner M; Schöne C; Feuchtinger A; Schuhmacher C; Novotny A; Jütting U; Maccarrone G; Sarioglu H; Ueffing M; Braselmann H; Zitzelsberger H; Schmid RM; Höfler H; Ebert MP; Walch A
    Am J Pathol; 2011 Dec; 179(6):2720-9. PubMed ID: 22015459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma.
    Li DJ; Deng G; Xiao ZQ; Yao HX; Li C; Peng F; Li MY; Zhang PF; Chen YH; Chen ZC
    Cancer Lett; 2009 Jun; 279(1):65-73. PubMed ID: 19231067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis.
    Tian T; Hao J; Xu A; Hao J; Luo C; Liu C; Huang L; Xiao X; He D
    Cancer Sci; 2007 Aug; 98(8):1265-74. PubMed ID: 17537172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers.
    Widegren E; Onnesjö S; Arbman G; Kayed H; Zentgraf H; Kleeff J; Zhang H; Sun XF
    Chemotherapy; 2009; 55(6):407-13. PubMed ID: 19955746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein.
    Hou Q; Tan HT; Lim KH; Lim TK; Khoo A; Tan IB; Yeoh KG; Chung MC
    J Proteome Res; 2013 Feb; 12(2):980-90. PubMed ID: 23265641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.